Cipla Ltd.
| BSE: 500087 | Sector: Health care |
| NSE: CIPLA | ISIN Code: INE059A01026 |
| BSE 14:50 | 26 May | 966.25 |
-5.10 (-0.53%) |
OPEN
971.50 |
HIGH
977.00 |
LOW
960.20 |
| NSE 14:34 | 26 May | 962.90 |
-8.95 (-0.92%) |
OPEN
972.10 |
HIGH
977.35 |
LOW
960.25 |
| OPEN | 971.50 |
| PREVIOUS CLOSE | 971.35 |
| VOLUME | 28574 |
| 52-Week high | 1083.15 |
| 52-Week low | 850.00 |
| P/E | 26.36 |
| Mkt Cap.(Rs cr) | 77,957 |
| Buy Price | 966.00 |
| Buy Qty | 52.00 |
| Sell Price | 966.85 |
| Sell Qty | 51.00 |
Cipla Ltd. (CIPLA) - Peer Group
| COMPANY | PRICE (In Rs) |
CHG (%) |
MKT CAP (Rs Cr) |
SALES (Rs Cr) |
PROFIT (Rs Cr) |
EPS (Rs) |
P/E (x) |
| Sun Pharma.Inds. | 896.05 | -1.66 | 214989.27 | 9863.06 | 2130.80 | 7.27 | 123.25 |
| Divi's Lab. | 3422.45 | -2.74 | 90848.94 | 2518.44 | 894.64 | 111.07 | 30.81 |
| Cipla | 966.25 | -0.53 | 77957.05 | 5260.33 | 376.72 | 36.66 | 26.36 |
| Dr Reddy's Labs | 4331.20 | 0.61 | 72079.83 | 5474.90 | 97.00 | 97.53 | 44.41 |
| Torrent Pharma. | 2899.50 | 10.06 | 49065.34 | 2108.00 | 249.00 | 61.99 | 46.77 |
| Gland Pharma | 2838.50 | 3.46 | 46721.71 | 1103.01 | 285.90 | 73.65 | 38.54 |
| Piramal Enterp. | 1840.10 | 1.60 | 43913.99 | 3816.16 | 887.96 | 14.45 | 127.34 |
| Biocon | 326.70 | 0.68 | 39223.60 | 2408.80 | 283.90 | 0.72 | 453.75 |
| Zydus Lifesci. | 369.60 | 0.91 | 37835.95 | 3863.80 | 448.70 | 10.68 | 34.61 |
| Abbott India | 17688.70 | -2.10 | 37588.49 | 1255.02 | 211.41 | 375.86 | 47.06 |
| Alkem Lab | 3007.15 | 1.33 | 35950.48 | 2483.86 | 108.21 | 128.90 | 23.33 |
| Aurobindo Pharma | 533.25 | 1.93 | 31243.12 | 6002.22 | 604.29 | 26.03 | 20.49 |
Quick Links for Cipla:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
